The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update
Open accessAbstract
The Epstein-Barr virus (EBV) is a DNA lymphotropic herpesvirus and the causative agent of infectious mononucleosis. EBV is highly prevalent since it affects more than 90% of individuals worldwide and has been linked to several malignancies including PTLDs, which are one of the most common malignancies following transplantation. Among all the EBV genes, most of the recent investigations focused on studying the LMP-1 oncogene because of its high degree of polymorphism and association with tumorigenic activity. There are two main EBV genotypes, Type 1 and 2, distinguished by the differences in the EBNA-2 gene. Further sub genotyping can be characterized by analyzing the LMP-1 gene variation. The virus primarily transmits through oral secretions and persists as a latent infection in human B-cells. However, it can be transmitted through organ transplantations and blood transfusions. In addition, symptoms of EBV infection are not distinguishable from other viral infections, and therefore, it remains questionable whether there is a need to screen for EBV prior to blood transfusion. Although the process of leukoreduction decreases the viral copies present in the leukocytes, it does not eliminate the risk of EBV transmission through blood products. Here, we provide a review of the EBV epidemiology and the genetic variability of the oncogene LMP-1. Then, we underscore the findings of recent EBV seroprevalence and viremia studies among blood donors as a highly prevalent transfusion transmissible oncovirus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
Wang, D., Liebowitz, D., & Kieff, E. (1985) · Cell · doi:10.1016/0092-8674(85)90256-9 · Cited by 1,225
(1948) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1948.tb28186.x · Cited by 1,141
Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report
Opelz, G., & Döhler, B. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00325.x · Cited by 1,081
Persistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas
Thorley-Lawson, D. A., & Gross, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032015 · Cited by 1,054
Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma
Lin, J.-C., Wang, W.-Y., Chen, K. Y., Wei, Y.-H., Liang, W.-M., Jan, J.-S., & Jiang, R.-S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032260 · Cited by 909
Epstein–Barr virus: more than 50 years old and still providing surprises
Young, L. S., Yap, L. F., & Murray, P. G. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.92 · Cited by 856
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis
Arvin, A. M., Campadelli‐Fiume, G., Mocarski, E. S., Moore, P. S., Roizman, B., Whitley, R. J., & Yamanishi, K. (2007) · Cited by 844
Greenspan, J. S., Greenspan, D., Lennette, E. T., Abrams, D. I., Conant, M. A., Petersen, V., & Freese, U. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132502 · Cited by 805
Thompson, M. P., & Kurzrock, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0670-3 · Cited by 786
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Kaye, K. M., Izumi, K. M., & Kieff, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9150 · Cited by 762
Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells
Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A., & Pagano, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405103101905 · Cited by 723
Yates, J., Warren, N., Reisman, D., & Sugden, B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3806 · Cited by 668
Laichalk, L. L., & Thorley-Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1296-1307.2005 · Cited by 538
Kilger, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1700 · Cited by 483
Malignant lymphomas in transplantation patients.
Penn, I., Hammond, W., BRETTSCHNEIDER, L., & Starzl, T. E. (1969) · PubMed · Cited by 469
Epstein-Barr virus infectious mononucleosis
Papesch, M., & Watkins, R. (2001) · Clinical Otolaryngology and Allied Sciences · doi:10.1046/j.1365-2273.2001.00431.x · Cited by 390
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis
(2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313 · Cited by 370
Rickinson, A. B., Young, L. S., & Rowe, M. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1310-1317.1987 · Cited by 369
Balfour, H. H., Odumade, O. A., Schmeling, D. O., Mullan, B. D., Ed, J. A., Knight, J. A., Vezina, H. E., Thomas, W., & Hogquist, K. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis646 · Cited by 337
Serological diagnosis of Epstein-Barr virus infection: Problems and solutions
De Paschale, M. (2012) · World Journal of Virology · doi:10.5501/wjv.v1.i1.31 · Cited by 333
Laboratory Assays for Epstein-Barr Virus-Related Disease
Gulley, M. L., & Tang, W. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080023 · Cited by 324
Hutt-Fletcher, L. M. (2007) · Journal of Virology · doi:10.1128/jvi.00445-07 · Cited by 323
Development of a Real-Time Quantitative Assay for Detection of Epstein-Barr Virus
Niesters, H. G. M., van Esser, J., Fries, E., Wolthers, K. C., Cornelissen, J., & Osterhaus, A. D. M. E. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.712-715.2000 · Cited by 305
Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.
Baichwal, V. R., & Sugden, B. (1988) · PubMed · Cited by 275
EBV-Associated Lymphoproliferative Disorders: Classification and Treatment
Carbone, A., Gloghini, A., & Dotti, G. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0036 · Cited by 263
Nh, P., PHILIPS, M., & Wf, W. (1964) · PubMed · Cited by 263
EBV-positive diffuse large B-cell lymphoma of the elderly
Ok, C. Y., Papathomas, T. G., Medeiros, L. J., & Young, K. H. (2013) · Blood · doi:10.1182/blood-2013-03-489708 · Cited by 260
Seroprevalence of Epstein-Barr Virus Infection in U.S. Children Ages 6-19, 2003-2010
Dowd, J. B., Palermo, T., Brite, J., McDade, T. W., & Aiello, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064921 · Cited by 260
Hu, L.-F., Zabarovsky, E. R., Chen, F., Cao, S.-L., Ernberg, I., Klein, G., & Winberg, G. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-10-2399 · Cited by 252
LMP1 structure and signal transduction
Eliopoulos, A. G., & Young, L. S. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0410 · Cited by 236
Hess, R. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3381-3387.2004 · Cited by 232
Reactivation of Epstein-Barr virus from latency
Amon, W., & Farrell, P. J. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.456 · Cited by 223
Balfour, H. H., Dunmire, S. K., & Hogquist, K. A. (2015) · Clinical & Translational Immunology · doi:10.1038/cti.2015.1 · Cited by 221
The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold
Humme, S., Reisbach, G., Feederle, R., Delecluse, H.-J., Bousset, K., Hammerschmidt, W., & Schepers, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832776100 · Cited by 214
Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cells
Shannon-Lowe, C. D., Neuhierl, B., Baldwin, G., Rickinson, A. B., & Delecluse, H.-J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510512103 · Cited by 206
Balfour, Jr., Holman, C. J., Hokanson, K. M., Lelonek, M. M., Giesbrecht, J. E., White, D. R., Schmeling, D. O., Webb, C., Cavert, W., Wang, D. H., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/491740 · Cited by 200
A Molecular Link between Malaria and Epstein–Barr Virus Reactivation
Chêne, A., Donati, D., Guerreiro-Cacais, A. O., Levitsky, V., Chen, Q., Falk, K. I., Orem, J., Kironde, F., Wahlgren, M., & Bejarano, M. T. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030080 · Cited by 191
Epstein-Barr virus and human diseases: recent advances in diagnosis
Okano, M., Thiele, G. M., Davis, J. R., Grierson, H. L., & Purtilo, D. T. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.3.300 · Cited by 190
Dunmire, S. K., Hogquist, K. A., & Balfour, H. H. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-22822-8_9 · Cited by 186
Epstein-Barr Virus Sequence Variation—Biology and Disease
Tzellos, S., & Farrell, P. (2012) · Pathogens · doi:10.3390/pathogens1020156 · Cited by 179
Epstein-Barr Virus and Infectious Mononucleosis
Henle, W., & Henle, G. (1973) · New England Journal of Medicine · doi:10.1056/nejm197302012880512 · Cited by 176
Moorthy, R. K., & Thorley-Lawson, D. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1638-1646.1993 · Cited by 172
Miller, W. E., Mosialos, G., Kieff, E., & Raab-Traub, N. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.586-594.1997 · Cited by 167
Chan, K. C. A., Hung, E. C. W., Woo, J. K. S., Chan, P. K. S., Leung, S., Lai, F. P. T., Cheng, A. S. M., Yeung, S. W., Chan, Y. W., Tsui, T. K. C., et al. (2013) · Cancer · doi:10.1002/cncr.28001 · Cited by 163
Kimura, H., Ito, Y., Suzuki, R., & Nishiyama, Y. (2008) · Reviews in Medical Virology · doi:10.1002/rmv.582 · Cited by 163
The epidemiology of EBV and its association with malignant disease
Hjalgrim, H., Friborg, J., & Melbye, M. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.054 · Cited by 154
Hayden, R. T., Hokanson, K. M., Pounds, S. B., Bankowski, M. J., Belzer, S. W., Carr, J., Diorio, D., Forman, M., Joshi, Y., Hillyard, D. R., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01252-07 · Cited by 138
Infection of Primary Human Monocytes by Epstein-Barr Virus
Savard, M., Bélanger, C., Tardif, M. R., Gourde, P., Flamand, L., & Gosselin, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2612-2619.2000 · Cited by 135
Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa
Adjei, A. A., Armah, H. B., Gbagbo, F., et al. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-111 · Cited by 133
Evidence-Based Approach for Interpretation of Epstein-Barr Virus Serological Patterns
Klutts, J. S., Ford, B. A., Perez, N. R., & Gronowski, A. M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00164-09 · Cited by 132
Faulkner, G. C., Burrows, S. R., Khanna, R., Moss, D. J., Bird, A. G., & Crawford, D. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1555-1564.1999 · Cited by 130
Shannon-Lowe, C. D., Adland, E., Bell, A. I., Delecluse, H., Rickinson, A. B., & Rowe, M. (2009) · Journal of Virology · doi:10.1128/jvi.00108-09 · Cited by 129
Kasahara, Y., & Yachie, A. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00119-1 · Cited by 123
Ok, C. Y., Li, L., & Young, K. H. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.82 · Cited by 122
Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines
Delecluse, H., Bartnizke, S., Hammerschmidt, W., Bullerdiek, J., & Bornkamm, G. W. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1292-1299.1993 · Cited by 107
Santpere, G., Darré, F., Blanco, S., Alcamí, A., Villoslada, P., Albà, M. M., & Navarro, A. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu054 · Cited by 105
Polz‐Dacewicz, M., Strycharz-Dudziak, M., Dworzański, J., Stec, A., & Kocot, J. (2016) · Infectious Agents and Cancer · doi:10.1186/s13027-016-0093-6 · Cited by 100
Smatti, M. K., Yassine, H. M., AbuOdeh, R., AlMarawani, A., Taleb, S., Thani, A. A. A., & Nasrallah, G. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189033 · Cited by 94
Self-citationEpstein-Barr Virus (EBV) DNA in Plasma Is Not Encapsidated in Patients With EBV-Related Malignancies
Ryan, J. L., Fan, H., Swinnen, L. J., Schichman, S. A., Raab‐Traub, N., Covington, M., Elmore, S., & Gulley, M. L. (2004) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200406000-00001 · Cited by 90
Detection of Cell-Free Epstein-Barr Virus DNA in Serum during Acute Infectious Mononucleosis
Gan, Y.-J., Sullivan, J. L., & Sixbey, J. W. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.2.436 · Cited by 88
Laboratory challenges in the diagnosis of hepatitis E virus
Al‐Sadeq, D. W., Majdalawieh, A. F., Mesleh, A. G., Abdalla, O. M., & Nasrallah, G. K. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000706 · Cited by 84
Self-citationRobertson, P., Beynon, S., Whybin, L. R., Brennan, C. M., Vollmer-Conna, U. S., Hickie, I. B., & Lloyd, A. R. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10439 · Cited by 79
Hudnall, S. D., Chen, T., Allison, P. M., Tyring, S. K., & Heath, A. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01685.x · Cited by 77
Deng, Z., Uehara, T., Maeda, H., Hasegawa, M., Matayoshi, S., Kiyuna, A., Agena, S., Pan, X., Zhang, C., Yamashita, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113702 · Cited by 73
Gärtner, B. C., Hess, R. D., Bandt, D., Kruse, A., Rethwilm, A., Roemer, K., & Mueller‐Lantzsch, N. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.1.78-82.2003 · Cited by 72
Correa, R. M., Fellner, M. D., Alonio, L. V., Durand, K., Teyssie, A. R., & Picconi, M. A. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20129 · Cited by 57
Guerreiro‐Cacais, A. O., Li, L., Donati, D., Bejarano, M. T., Morgan, A. J., Masucci, M. G., Hutt‐Fletcher, L. M., & Levitsky, V. (2004) · Journal of General Virology · doi:10.1099/vir.0.80140-0 · Cited by 57
Evaluation of Four Commercial Systems for the Diagnosis of Epstein-Barr Virus Primary Infections
de Ory, F., Guisasola, M. E., Sanz, J. C., & García-Bermejo, I. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00486-10 · Cited by 56
Moustafa, A. A., Al‐Antary, N., Aboulkassim, T., Akil, N., Batist, G., & Yasmeen, A. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1139255 · Cited by 56
Gieß, R. M., Pfuhl, C., Behrens, J. R., Rasche, L., Freitag, E., Khalighy, N., Otto, C., Wuerfel, J. T., Brandt, A. U., Hofmann, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175279 · Cited by 55
Prospective studies of infectious mononucleosis in university students
Grimm, J., Schmeling, D. O., Dunmire, S. K., Knight, J. A., Mullan, B. D., Ed, J. A., Brundage, R. C., Hogquist, K. A., & Balfour, H. H. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.48 · Cited by 54
Epstein–Barr Virus Strain Variation
Farrell, P. J. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22822-8_4 · Cited by 53
Visconti, M. R., Pennington, J., Garner, S. F., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0762 · Cited by 38
Guerrero-Ramos, A., Patel, M., Kadakia, K., & Haque, T. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00754-13 · Cited by 36
Kieser, A. (2008) · Biological Chemistry · doi:10.1515/bc.2008.144 · Cited by 36
Berth, M., & Bosmans, E. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00380-08 · Cited by 34
Cui, Y., Wang, Y., Liu, X., et al. (2010) · Intervirology · doi:10.1159/000319632 · Cited by 26
Bangalore-Prakash, P., Stunz, L. L., Mambetsariev, N., Whillock, A. L., Hostager, B. S., & Bishop, G. A. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017009670 · Cited by 21
Epstein-Barr virus in healthy individuals from Portugal.
de Sousa, H. M. L., Silva, J. S., Azevedo, L. F., Pinto-Correia, A. L., Catarino, R., Pinto, D., Lopes, C., & Medeiros, R. (2011) · PubMed · doi:10.20344/amp.517 · Cited by 20
A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2
Gatto, F., Cassina, G., Broccolo, F., Morreale, G., Lanino, E., Marco, E. D., Vardas, E., Bernasconi, D., Buttò, S., Principi, N., et al. (2011) · Journal of Virological Methods · doi:10.1016/j.jviromet.2011.08.022 · Cited by 13
Ikuta, K., Saiga, K., Deguchi, M., & Sairenji, T. (2003) · Virus Genes · doi:10.1023/a:1023487413912 · Cited by 9
Cited by
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
Gold, J. E., Okyay, R. A., Licht, W. E., & Hurley, D. J. (2021) · Pathogens · doi:10.3390/pathogens10060763 · Cited by 371
Ghosh, S., Shetty, R. S., Pattanshetty, S. M., Mallya, S. D., Pandey, D., Kabekkodu, S. P., Kamath, V. G., Prabhu, N., D’souza, J., & Satyamoorthy, K. (2019) · PLOS ONE · doi:10.1371/journal.pone.0219173 · Cited by 27
Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment
Viegas, C., Pereira, D. S. M., & Fonte, P. (2022) · Materials · doi:10.3390/ma15062086 · Cited by 21
Metadata
- Authors
- Smatti, M. K., Al-Sadeq, D. W., Ali, N. H., Pintus, G., Abou-Saleh, H., & Nasrallah, G. K.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2018-06-13
- Volume
- 8
- Pages
- 211-211
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2808143659
- Cited by
- 309
- References
- 84
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.